A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 109,084 shares of NVS stock, worth $10.7 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
109,084
Previous 114,342 4.6%
Holding current value
$10.7 Million
Previous $12.2 Million 3.07%
% of portfolio
0.66%
Previous 0.69%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $558,031 - $635,639
-5,258 Reduced 4.6%
109,084 $12.5 Million
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $636,696 - $738,490
-6,878 Reduced 5.67%
114,342 $12.2 Million
Q1 2024

May 07, 2024

BUY
$95.27 - $108.47 $11.5 Million - $13.1 Million
121,220 New
121,220 $11.7 Million
Q4 2023

Feb 07, 2024

SELL
$92.27 - $101.54 $130,931 - $144,085
-1,419 Reduced 1.12%
125,105 $12.6 Million
Q3 2023

Nov 09, 2023

SELL
$94.73 - $105.13 $190,596 - $211,521
-2,012 Reduced 1.57%
126,524 $12.9 Million
Q2 2023

Aug 09, 2023

SELL
$92.52 - $104.91 $417,727 - $473,668
-4,515 Reduced 3.39%
128,536 $13 Million
Q1 2023

May 03, 2023

SELL
$80.03 - $92.81 $616,551 - $715,008
-7,704 Reduced 5.47%
133,051 $12.2 Million
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $86,655 - $106,120
1,147 Added 0.82%
140,755 $12.8 Million
Q3 2022

Nov 08, 2022

BUY
$74.61 - $87.26 $178,094 - $208,289
2,387 Added 1.74%
139,608 $10.6 Million
Q2 2022

Aug 05, 2022

BUY
$80.52 - $93.75 $724,438 - $843,468
8,997 Added 7.02%
137,221 $11.6 Million
Q1 2022

May 11, 2022

SELL
$80.11 - $90.62 $111,433 - $126,052
-1,391 Reduced 1.07%
128,224 $11.3 Million
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $21,040 - $23,266
264 Added 0.2%
129,615 $11.3 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $51,521 - $59,938
-630 Reduced 0.48%
129,351 $10.6 Million
Q2 2021

Aug 12, 2021

SELL
$85.24 - $94.15 $2.76 Million - $3.05 Million
-32,366 Reduced 19.94%
129,981 $11.9 Million
Q1 2021

May 07, 2021

SELL
$83.5 - $98.47 $2.72 Million - $3.21 Million
-32,595 Reduced 16.72%
162,347 $13.9 Million
Q4 2020

Feb 10, 2021

SELL
$78.07 - $94.43 $409,086 - $494,813
-5,240 Reduced 2.62%
194,942 $18.4 Million
Q3 2020

Oct 28, 2020

SELL
$82.14 - $91.0 $550,748 - $610,155
-6,705 Reduced 3.24%
200,182 $17.4 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $2.89 Million - $3.25 Million
-35,704 Reduced 14.72%
206,887 $18.1 Million
Q1 2020

May 13, 2020

SELL
$70.67 - $99.01 $753,412 - $1.06 Million
-10,661 Reduced 4.21%
242,591 $20 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $576,954 - $652,330
-6,840 Reduced 2.63%
253,252 $24 Million
Q3 2019

Nov 08, 2019

SELL
$85.54 - $94.26 $1.55 Million - $1.71 Million
-18,146 Reduced 6.52%
260,092 $22.6 Million
Q2 2019

Aug 06, 2019

SELL
$75.4 - $92.8 $1.48 Million - $1.82 Million
-19,603 Reduced 6.58%
278,238 $25.4 Million
Q1 2019

May 10, 2019

BUY
$75.32 - $86.15 $69,520 - $79,516
923 Added 0.31%
297,841 $28.6 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $31,452 - $35,022
-427 Reduced 0.14%
296,918 $25.5 Million
Q3 2018

Nov 26, 2018

BUY
$66.94 - $77.43 $88,026 - $101,820
1,315 Added 0.44%
297,345 $25.6 Million
Q2 2018

Aug 09, 2018

SELL
$64.91 - $73.36 $2.31 Million - $2.61 Million
-35,522 Reduced 10.71%
296,030 $22.4 Million
Q1 2018

Jul 26, 2018

BUY
$70.39 - $84.15 $21.5 Million - $25.6 Million
304,746 Added 1136.86%
331,552 $26.8 Million
Q1 2018

May 03, 2018

SELL
$70.39 - $84.15 $18.8 Million - $22.5 Million
-267,109 Reduced 90.88%
26,806 $332 Million
Q4 2017

Feb 06, 2018

SELL
$72.33 - $77.64 $909,115 - $975,857
-12,569 Reduced 4.1%
293,915 $0
Q3 2017

Nov 09, 2017

BUY
$74.14 - $77.27 $733,170 - $764,123
9,889 Added 3.33%
306,484 $26.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
296,595
296,595 $24.8 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.